Amicus Therapeutics Inc (FOLD)
10.09
-0.28
(-2.70%)
USD |
NASDAQ |
Nov 14, 16:00
10.10
+0.02
(+0.15%)
After-Hours: 20:00
Amicus Therapeutics Cash and Short Term Investments (Quarterly): 249.76M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 249.76M |
| June 30, 2024 | 260.06M |
| March 31, 2024 | 239.60M |
| December 31, 2023 | 286.20M |
| September 30, 2023 | 280.30M |
| June 30, 2023 | 265.63M |
| March 31, 2023 | 267.11M |
| December 31, 2022 | 293.60M |
| September 30, 2022 | 354.70M |
| June 30, 2022 | 386.84M |
| March 31, 2022 | 411.20M |
| December 31, 2021 | 482.50M |
| September 30, 2021 | 556.96M |
| June 30, 2021 | 383.07M |
| March 31, 2021 | 417.43M |
| December 31, 2020 | 483.27M |
| September 30, 2020 | 509.08M |
| June 30, 2020 | 309.59M |
| March 31, 2020 | 338.87M |
| December 31, 2019 | 452.74M |
| September 30, 2019 | 514.19M |
| June 30, 2019 | 575.66M |
| March 31, 2019 | 438.33M |
| December 31, 2018 | 504.15M |
| September 30, 2018 | 564.38M |
| Date | Value |
|---|---|
| June 30, 2018 | 538.95M |
| March 31, 2018 | 562.52M |
| December 31, 2017 | 358.56M |
| September 30, 2017 | 411.52M |
| June 30, 2017 | 227.23M |
| March 31, 2017 | 279.84M |
| December 31, 2016 | 330.35M |
| September 30, 2016 | 212.40M |
| June 30, 2016 | 214.15M |
| March 31, 2016 | 165.85M |
| December 31, 2015 | 214.03M |
| September 30, 2015 | 236.51M |
| June 30, 2015 | 361.42M |
| March 31, 2015 | 148.77M |
| December 31, 2014 | 151.68M |
| September 30, 2014 | 85.18M |
| June 30, 2014 | 78.00M |
| March 31, 2014 | 71.65M |
| December 31, 2013 | 82.00M |
| September 30, 2013 | 60.50M |
| June 30, 2013 | 74.18M |
| March 31, 2013 | 84.75M |
| December 31, 2012 | 99.12M |
| September 30, 2012 | 106.22M |
| June 30, 2012 | 95.77M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
239.60M
Minimum
Mar 2024
556.96M
Maximum
Sep 2021
361.42M
Average
346.79M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 4.156M |
| Alnylam Pharmaceuticals Inc | 2.780B |
| Ionis Pharmaceuticals Inc | 2.483B |
| Arbutus Biopharma Corp | 127.79M |
| Krystal Biotech Inc | 588.32M |